From 2007 to 2018, claim lines1 with diagnoses of Lyme disease increased nationally 117%, according to a new white paper from FAIR Health, a national, independent nonprofit organization dedicated to bringing transparency to healthcare costs and health insurance information. Comparing Lyme disease to other tick-borne diseases, the study draws on data from FAIR Health’s comprehensive repository of over 29 billion private healthcare claim records—the largest in the country.
A bacterial infection transmitted through the bite of blacklegged ticks, Lyme disease historically has been associated more with rural than urban areas. But the new study shows that the growth in claim lines from 2007 to 2018 was more pronounced in urban locations. In urban areas, the increase was 121%, compared to 105% in rural areas—a difference perhaps attributable in part to people seeking care for the disease in or around their urban homes or work environments notwithstanding Report Bughaving contracted Lyme in a rural setting.
The white paper originated as an invited presentation to the Tick-Borne Disease Working Group’s Subcommittee on Training, Education, Access to Care and Reimbursement.2 Congress established the Tick-Borne Disease Working Group as part of the 21st Century Cures Act of 2016.
Among the white paper’s other findings:
Predominance. Claim lines for Lyme disease accounted for 94% of claim lines for tick-borne diseases in 2018.
Geographic spread. In 2007, the 5 states with the highest number of claim lines with Lyme disease diagnoses as a percentage of all medical claim lines by state were all in the Northeast, but in 2018, 1 (North Carolina) was in the South.
Gender. In both rural and urban areas in 2018, more claim lines with Lyme disease diagnoses were submitted for females than males (Figure 1).
Figure 1. Distribution of Claim Lines with Lyme Disease Diagnoses by Gender in Rural (Left) and Urban (Right) Areas, 2018
Other diagnoses. In 2018, the 10 most common “other diagnoses” found in patients who had been diagnosed with Lyme disease were, in order from most to least common, general signs and symptoms, dorsopathies (disorders of the spine), soft tissue disorders, other joint disorders, disorders of the thyroid gland, anxiety and other nonpsychotic mental disorders, osteoarthritis, skin and subcutaneous tissue symptoms, dermatitis and eczema, and mood (affective) disorders (Figure 2). All were more common in patients with Lyme disease than in all patients.
Figure 2. 10 Most Common Other Diagnoses by Mid-Level Diagnostic Category in Patients Diagnosed with Lyme Disease (Lyme Patients) versus All Patients, 2018
Age. In both rural and urban areas in 2018, individuals aged 51 to 60 held the largest share of the age distribution of claim lines with Lyme disease diagnoses (Figure 3). The age group 41-50 held the second largest share in both rural and urban areas.
Figure 3. Distribution of Claim Lines with Lyme Disease Diagnoses by Age Group and Rural or Urban Area, 2018
Monthly distribution. In 2018, July was the month with the highest share of the distribution of claim lines for Lyme disease (Figure 4). The month with the lowest share was December.
Figure 4. Monthly Distribution of Claim Lines with Lyme Disease Diagnoses, 2018
FAIR Health is pleased to use its unequaled data repository to help fill the gaps in knowledge about Lyme disease. Our study provides a foundation to advance the work of other researchers.
Notes
Author Information
Robin Gelburd, JD, is the President of FAIR Health, a national, independent nonprofit organization with the mission of bringing transparency to healthcare costs and health insurance information. FAIR Health possesses the nation’s largest collection of private healthcare claims data, which includes over 29 billion claim records contributed by payors and administrators who insure or process claims for private insurance plans covering more than 150 million individuals. Certified by the Centers for Medicare & Medicaid Services (CMS) as a national Qualified Entity, FAIR Health also receives data representing the experience of all individuals enrolled in traditional Medicare Parts A, B and D; FAIR Health houses data on Medicare Advantage enrollees in its private claims data repository. Robin is a nationally recognized expert on healthcare policy, data and transparency.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Pulmonary Hypertension Subtypes Show Distinct PA Flow Hemodynamics
March 21st 2025Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) remodeling in pulmonary arterial hypertension and other types of pulmonary hypertension.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
FDA Approves Vutrisiran to Mitigate Cardiomyopathy-Related Risks and Conditions
March 21st 2025In a recent decision, the FDA approved vutrisiran (amvuttra), making it the only approved therapy for adults with hereditary transthyretin-mediated amyloidosis (ATTR-CM) or wild-type cardiomyopathy.
Read More
Streamlining "Brain-to-Vein" Time, Patient Selection, Imperative for Implementing CAR T for MM
March 21st 2025Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.
Read More